AAPL346.04+2.05 (+0.60%) ▲|ABBV284.56-0.24 (-0.09%) ▼|ABT102.44+1.93 (+1.92%) ▲|ACN251.79+11.53 (+4.80%) ▲|ADBE269.35+14.29 (+5.60%) ▲|AMAT379.67-29.27 (-7.16%) ▼|AMD510.23-42.50 (-7.69%) ▼|AMGN448.43+10.09 (+2.30%) ▲|AMT180.83+3.19 (+1.80%) ▲|AMZN250.25-12.13 (-4.62%) ▼|AVGO324.69-13.11 (-3.88%) ▼|AXP324.15+0.54 (+0.17%) ▲|BA188.42-3.86 (-2.01%) ▼|BAC50.92+0.14 (+0.28%) ▲|BKNG161.73+3.35 (+2.12%) ▲|BLK1,140.28-9.32 (-0.81%) ▼|BMY63.40+2.28 (+3.73%) ▲|BNY144.39-1.47 (-1.00%) ▼|BRK-B549.50+10.51 (+1.95%) ▲|C122.00-1.85 (-1.49%) ▼|CAT700.46-39.75 (-5.37%) ▼|CL97.26+3.86 (+4.13%) ▲|CMCSA22.72+0.64 (+2.91%) ▲|COF203.62-3.05 (-1.47%) ▼|COP146.03+0.36 (+0.25%) ▲|COST1,013.81+15.50 (+1.55%) ▲|CRM249.84+8.06 (+3.33%) ▲|CSCO104.94-2.33 (-2.17%) ▼|CVS94.12+1.34 (+1.44%) ▲|CVX226.22-0.57 (-0.25%) ▼|DE639.41+2.87 (+0.45%) ▲|DHR229.92-3.94 (-1.69%) ▼|DIS112.61+0.78 (+0.70%) ▲|DUK124.83+4.16 (+3.45%) ▲|EMR158.07-5.04 (-3.09%) ▼|FDX302.92+4.69 (+1.57%) ▲|GD348.39+3.68 (+1.07%) ▲|GE290.18-5.70 (-1.93%) ▼|GEV822.47-103.45 (-11.17%) ▼|GILD156.80+3.23 (+2.10%) ▲|GM76.72+0.61 (+0.79%) ▲|GOOG320.83-10.12 (-3.06%) ▼|GOOGL324.44-10.33 (-3.08%) ▼|GS887.73-16.99 (-1.88%) ▼|HD325.72+11.58 (+3.69%) ▲|HON215.32+0.59 (+0.27%) ▲|IBM249.87-1.59 (-0.63%) ▼|INTC86.11-6.85 (-7.37%) ▼|INTU353.97+18.36 (+5.47%) ▲|ISRG441.26+13.14 (+3.07%) ▲|JNJ268.91+11.13 (+4.32%) ▲|JPM334.80-0.39 (-0.12%) ▼|KO94.84+2.16 (+2.33%) ▲|LIN509.77+9.20 (+1.84%) ▲|LLY1,311.52+40.77 (+3.21%) ▲|LMT585.45+33.94 (+6.15%) ▲|LOW203.10+6.54 (+3.33%) ▲|LRCX231.69-29.12 (-11.17%) ▼|MA631.79+9.17 (+1.47%) ▲|MCD251.63+5.38 (+2.18%) ▲|MDLZ64.91+2.17 (+3.45%) ▲|MDT95.58+2.55 (+2.74%) ▲|META645.44-52.08 (-7.47%) ▼|MMM174.08-0.66 (-0.38%) ▼|MO75.86+2.03 (+2.74%) ▲|MRK147.96-1.92 (-1.28%) ▼|MS183.29-3.73 (-1.99%) ▼|MSFT523.97-8.98 (-1.69%) ▼|MU860.14-53.53 (-5.86%) ▼|NEE81.39+3.11 (+3.97%) ▲|NFLX67.22+2.18 (+3.35%) ▲|NKE38.27+0.74 (+1.96%) ▲|NOW156.69+3.57 (+2.33%) ▲|NVDA212.50-9.47 (-4.27%) ▼|ORCL123.41-5.72 (-4.43%) ▼|PEP138.27+3.57 (+2.65%) ▲|PFE30.25+0.40 (+1.34%) ▲|PG166.12+9.28 (+5.92%) ▲|PLTR197.07-4.65 (-2.31%) ▼|PM200.87+3.41 (+1.73%) ▲|QCOM172.75-5.22 (-2.93%) ▼|RTX192.53+0.93 (+0.49%) ▲|SBUX101.62+2.54 (+2.56%) ▲|SCHW92.21+0.57 (+0.62%) ▲|SO93.28+2.89 (+3.20%) ▲|SPG211.18+5.63 (+2.74%) ▲|T22.68+0.77 (+3.49%) ▲|TMO676.83-17.19 (-2.48%) ▼|TMUS158.27+4.52 (+2.94%) ▲|TSLA377.95-8.53 (-2.21%) ▼|TXN283.23-1.42 (-0.50%) ▼|UBER68.21+0.59 (+0.87%) ▲|UNH424.60+7.60 (+1.82%) ▲|UNP296.04+8.17 (+2.84%) ▲|UPS101.69+2.12 (+2.12%) ▲|USB59.91+0.86 (+1.45%) ▲|V413.95+6.10 (+1.50%) ▲|VZ44.80+1.24 (+2.84%) ▲|WFC83.02+0.60 (+0.73%) ▲|WMT120.45+2.65 (+2.25%) ▲|XOM177.34-0.75 (-0.42%) ▼|AAPL346.04+2.05 (+0.60%) ▲|ABBV284.56-0.24 (-0.09%) ▼|ABT102.44+1.93 (+1.92%) ▲|ACN251.79+11.53 (+4.80%) ▲|ADBE269.35+14.29 (+5.60%) ▲|AMAT379.67-29.27 (-7.16%) ▼|AMD510.23-42.50 (-7.69%) ▼|AMGN448.43+10.09 (+2.30%) ▲|AMT180.83+3.19 (+1.80%) ▲|AMZN250.25-12.13 (-4.62%) ▼|AVGO324.69-13.11 (-3.88%) ▼|AXP324.15+0.54 (+0.17%) ▲|BA188.42-3.86 (-2.01%) ▼|BAC50.92+0.14 (+0.28%) ▲|BKNG161.73+3.35 (+2.12%) ▲|BLK1,140.28-9.32 (-0.81%) ▼|BMY63.40+2.28 (+3.73%) ▲|BNY144.39-1.47 (-1.00%) ▼|BRK-B549.50+10.51 (+1.95%) ▲|C122.00-1.85 (-1.49%) ▼|CAT700.46-39.75 (-5.37%) ▼|CL97.26+3.86 (+4.13%) ▲|CMCSA22.72+0.64 (+2.91%) ▲|COF203.62-3.05 (-1.47%) ▼|COP146.03+0.36 (+0.25%) ▲|COST1,013.81+15.50 (+1.55%) ▲|CRM249.84+8.06 (+3.33%) ▲|CSCO104.94-2.33 (-2.17%) ▼|CVS94.12+1.34 (+1.44%) ▲|CVX226.22-0.57 (-0.25%) ▼|DE639.41+2.87 (+0.45%) ▲|DHR229.92-3.94 (-1.69%) ▼|DIS112.61+0.78 (+0.70%) ▲|DUK124.83+4.16 (+3.45%) ▲|EMR158.07-5.04 (-3.09%) ▼|FDX302.92+4.69 (+1.57%) ▲|GD348.39+3.68 (+1.07%) ▲|GE290.18-5.70 (-1.93%) ▼|GEV822.47-103.45 (-11.17%) ▼|GILD156.80+3.23 (+2.10%) ▲|GM76.72+0.61 (+0.79%) ▲|GOOG320.83-10.12 (-3.06%) ▼|GOOGL324.44-10.33 (-3.08%) ▼|GS887.73-16.99 (-1.88%) ▼|HD325.72+11.58 (+3.69%) ▲|HON215.32+0.59 (+0.27%) ▲|IBM249.87-1.59 (-0.63%) ▼|INTC86.11-6.85 (-7.37%) ▼|INTU353.97+18.36 (+5.47%) ▲|ISRG441.26+13.14 (+3.07%) ▲|JNJ268.91+11.13 (+4.32%) ▲|JPM334.80-0.39 (-0.12%) ▼|KO94.84+2.16 (+2.33%) ▲|LIN509.77+9.20 (+1.84%) ▲|LLY1,311.52+40.77 (+3.21%) ▲|LMT585.45+33.94 (+6.15%) ▲|LOW203.10+6.54 (+3.33%) ▲|LRCX231.69-29.12 (-11.17%) ▼|MA631.79+9.17 (+1.47%) ▲|MCD251.63+5.38 (+2.18%) ▲|MDLZ64.91+2.17 (+3.45%) ▲|MDT95.58+2.55 (+2.74%) ▲|META645.44-52.08 (-7.47%) ▼|MMM174.08-0.66 (-0.38%) ▼|MO75.86+2.03 (+2.74%) ▲|MRK147.96-1.92 (-1.28%) ▼|MS183.29-3.73 (-1.99%) ▼|MSFT523.97-8.98 (-1.69%) ▼|MU860.14-53.53 (-5.86%) ▼|NEE81.39+3.11 (+3.97%) ▲|NFLX67.22+2.18 (+3.35%) ▲|NKE38.27+0.74 (+1.96%) ▲|NOW156.69+3.57 (+2.33%) ▲|NVDA212.50-9.47 (-4.27%) ▼|ORCL123.41-5.72 (-4.43%) ▼|PEP138.27+3.57 (+2.65%) ▲|PFE30.25+0.40 (+1.34%) ▲|PG166.12+9.28 (+5.92%) ▲|PLTR197.07-4.65 (-2.31%) ▼|PM200.87+3.41 (+1.73%) ▲|QCOM172.75-5.22 (-2.93%) ▼|RTX192.53+0.93 (+0.49%) ▲|SBUX101.62+2.54 (+2.56%) ▲|SCHW92.21+0.57 (+0.62%) ▲|SO93.28+2.89 (+3.20%) ▲|SPG211.18+5.63 (+2.74%) ▲|T22.68+0.77 (+3.49%) ▲|TMO676.83-17.19 (-2.48%) ▼|TMUS158.27+4.52 (+2.94%) ▲|TSLA377.95-8.53 (-2.21%) ▼|TXN283.23-1.42 (-0.50%) ▼|UBER68.21+0.59 (+0.87%) ▲|UNH424.60+7.60 (+1.82%) ▲|UNP296.04+8.17 (+2.84%) ▲|UPS101.69+2.12 (+2.12%) ▲|USB59.91+0.86 (+1.45%) ▲|V413.95+6.10 (+1.50%) ▲|VZ44.80+1.24 (+2.84%) ▲|WFC83.02+0.60 (+0.73%) ▲|WMT120.45+2.65 (+2.25%) ▲|XOM177.34-0.75 (-0.42%) ▼|
19.5 C
New York
Thursday, October 22, 2026

Tag: presentations

newsFORsourcecompanycontentinformation1releasesmarket

Superior Group of Companies to Announce Second Quarter 2025 Results

ST. PETERSBURG, Fla., July 22, 2025 (GLOBE NEWSWIRE) -- Superior Group of Companies, Inc. (NASDAQ: SGC) (the “Company”) today announced that it will release the results of its operations for the second quarter 2025 after the market close on Tuesday, August 5, 2025. Michael Benstock, Chairman, President and Chief Executive Officer, and Mike Koempel, Chief Financial Officer, will host a teleconference at 5:00 pm Eastern Time that day to discuss the Company’s results.

Rhythm Pharmaceuticals to Report Second Quarter 2025 Financial Results on Tuesday, August 5, 2025

BOSTON, July 22, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Tuesday, August 5, 2025 to report its second quarter 2025 financial results and provide a corporate update.

Analysis Group Co-Authors Examine the Advancements in and Application of Health Economics and Outcomes Research to the Evaluation of Cell and Gene Therapies for...

BOSTON, July 22, 2025 /PRNewswire/ -- In a new article published in Value in Health, researchers from Analysis Group, a global leader in health economics...

Stoneridge, Inc. To Broadcast Its Second Quarter 2025 Conference Call On The Web

NOVI, Mich., July 22, 2025 /PRNewswire/ -- Stoneridge, Inc. (NYSE: SRI) will webcast its second quarter 2025 earnings conference call live on Thursday, August...

Anterix Sets First Quarter Fiscal 2026 Earnings Conference Call for Wednesday, August 13, at 9:00 a.m. ET

WOODLAND PARK, N.J., July 22, 2025 (GLOBE NEWSWIRE) -- Anterix (NASDAQ: ATEX) announced today that it will hold a conference call on Wednesday, August 13, 2025, at 9:00 a.m. ET. Anterix senior management, led by President and CEO Scott Lang, will discuss the Company's first quarter fiscal 2026 results. A press release regarding the results will be issued after the close of the market on Tuesday, August 12, 2025.

Andean Silver to Present at the Metals & Mining Virtual Investor Conference July 23

Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com 
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com

Metals & Mining Virtual Investor Conference Agenda Announced for July 23rd and 24th

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

uniQure to Announce Second Quarter 2025 Financial Results

uniQure to host earnings call on Tuesday, July 29, 2025 at 8:30 a.m. ET 
uniQure to host earnings call on Tuesday, July 29, 2025 at 8:30 a.m. ET

Securitas AB to publish the Interim Report January-June 2025 on July 30, 2025

STOCKHOLM, July 22, 2025 /PRNewswire/ -- Securitas AB will publish the Interim Report January-June 2025 on Wednesday July 30, 2025, at 8.00 a.m. (CEST). 8.00...

Telix Reports $204M Revenue, Up 63% YOY

MELBOURNE, Australia and INDIANAPOLIS, July 22, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today provides an update on its commercial and operational performance for the quarter ended 30 June 2025 (Q2 2025). All figures are in USD unless stated otherwise.

Lecanemab four-year efficacy and safety data to be presented at AAIC 2025

STOCKHOLM, July 22, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai will present the latest findings on lecanemab (Leqembi®), including...

Biogen to Highlight Scientific Progress Across Alzheimer’s Disease at the Alzheimer’s Association International Conference 2025

CAMBRIDGE, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced upcoming scientific presentations at the 2025 Alzheimer’s Association International Conference (AAIC), taking place July 27-31 in Toronto, Canada. Data on LEQEMBI® (lecanemab) will include 48-month results from the Clarity AD open-label extension, real-world evidence, and new insights into a subcutaneous formulation for maintenance dosing. Presentations on tau will explore tau-targeted therapies and biomarkers, including baseline characteristics of participants from CELIA, a Phase 2 trial evaluating the efficacy, safety, and tolerability of BIIB080, an investigational antisense oligonucleotide (ASO) therapy that targets tau.

EISAI TO PRESENT FOUR-YEAR EFFICACY AND SAFETY DATA ON CONTINUOUS TREATMENT WITH LECANEMAB AT THE ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE 2025

Latest findings from Eisai's robust Alzheimer's disease (AD) pipeline include results from lecanemab long-term data, an immunoassay for measuring amyloid-β protofibrils in cerebrospinal fluid,...

MSA Safety Schedules Second Quarter 2025 Earnings Conference Call

PITTSBURGH, July 21, 2025 /PRNewswire/ -- MSA Safety Incorporated (NYSE: MSA), a global leader in the development of advanced safety products and solutions that...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPresentations

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers